Unusual Machines, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
UMAC$12.59-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Consolidated Condensed Statements of Cash Flows
Consolidated Condensed Statement of Cash Flows
For the Nine Months Ended September 30, 2026 and 2025
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $(22,545,507) | $(8,627,553) |
| Depreciation and amortization | 390,717 | 63,635 |
| Stock-based compensation expense | 15,073,154 | 9,522,261 |
| Unrealized loss (gain) on short-term investments | 12,773,139 | (5,849,713) |
| Realized gain on short-term investments | (9,532,673) | – |
| Bad debt | – | 12,146 |
| Contingent consideration | 153,000 | – |
| Change in assets and liabilities: | ||
| Accounts receivable | (16,923,933) | (122,696) |
| Inventories | (37,305,429) | (1,746,100) |
| Prepaid inventory | (13,510,540) | (6,016,951) |
| Other assets | (1,225,625) | (165,529) |
| Right of use asset and lease liabilities | 74,071 | (8,144) |
| Note Receivable | (5,000,000) | – |
| Accounts payable and accrued expenses | 4,549,114 | 406,399 |
| Deferred revenue and other current liabilities | (523,634) | 1,137,953 |
| Net cash used in operating activities | (73,554,146) | (11,394,292) |
| Cash flows from investing activities | ||
| Acquisition of businesses, net of cash received | – | 93,054 |
| Investments in short-term securities | (82,499,998) | (11,000,000) |
| Proceeds from sale of short-term investments | 20,082,674 | – |
| Purchase of property and equipment | (6,481,450) | (1,550,687) |
| Purchase of intangible assets (patents) | (7,980) | – |
| Net cash used in investing activities | (68,906,754) | (12,457,633) |
| Cash flows from financing activities: | ||
| Gross proceeds from issuance of common shares, public offering | 149,999,993 | 40,000,000 |
| Gross proceeds from issuance of common shares, registered direct offering | – | 48,500,000 |
| Gross proceeds from issuance of common shares, at the market | 60,000,000 | – |
| Proceeds from option exercises | 750,373 | 501,610 |
| Proceeds from issuance of common shares, warrant exercises | 3,395,000 | 2,479,466 |
| Common share issuance offering costs | (13,001,236) | (7,103,000) |
| Net cash provided by financing activities | 201,144,130 | 84,378,076 |
| Net increase in cash | 58,683,230 | 60,526,149 |
| Effect of exchange rates changes on cash | 20,878 | 2,278 |
| Cash, beginning of period | 103,261,397 | 3,757,323 |
| Cash, end of period | $161,965,505 | $64,285,750 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.